台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    87.9
  • 漲跌
    ▼2.2
  • 漲幅
    -2.44%
  • 成交量
    1,102
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147)籌碼相關-凱基-林口 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/0380859095100105110May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

凱基-林口 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/02188.1000.0087.9012,2940.04%
2025/03/31189.5000.0088.0012,2770.04%
2025/03/28194.4000.0093.8012,2570.04%
2025/03/27396.1000.0096.1032,2480.13%
2025/03/2600.00299.4098.10-22,230-0.09%
2025/03/2500.00297.4098.60-22,210-0.09%
2025/03/2400.00199.2099.00-12,192-0.05%
2025/03/21297.7000.0096.4022,1490.09%
2025/03/2000.00295.8095.80-22,123-0.09%
2025/03/13597.1000.0091.6052,0990.24%
2025/03/07195.20295.9096.50-11,991-0.05%
2025/03/05198.5000.0098.6011,9240.05%
2025/03/03296.0000.0094.2021,8870.11%
2025/02/2700.00396.6095.50-31,878-0.16%
2025/02/26199.1000.0098.0011,8860.05%
2025/02/254101.381101.0099.3031,8560.16%
2025/02/242101.5000.0099.3021,7960.11%
2025/02/21299.557104.2998.90-51,727-0.29%
2025/02/2000.00196.3099.70-11,553-0.06%
2025/02/1800.00495.5594.00-41,491-0.27%
2025/02/173.2104.343102.5097.100.21,4400.01%
2025/02/11591.9400.0091.7051,1400.44%
2025/02/0400.000.183.4083.30-0.11,1140.00%
2025/01/16286.8000.0086.5021,1330.18%
2025/01/1400.000.489.7087.30-0.41,147-0.04%
2025/01/13388.2000.0089.9031,1320.26%
2025/01/09390.50292.9587.5011,0140.10%
2025/01/082.1101.468101.1997.20-6872-0.68%
2024/12/1800.00382.7082.90-3626-0.48%
2024/11/2500.00185.0085.00-1543-0.18%
2024/11/0700.00281.8581.60-2525-0.38%
2024/10/1800.00174.7073.60-1584-0.17%
2024/10/0100.00179.6079.40-1635-0.16%
2024/08/0800.00276.7076.70-2783-0.26%
2024/08/0100.001083.5184.50-10715-1.40%
2024/07/1700.001088.2088.10-10713-1.40%
2024/07/1600.00186.3085.60-1720-0.14%
2024/07/15285.5500.0086.3027470.27%
2024/07/1200.00384.5085.30-3757-0.40%
2024/07/11185.00285.5084.90-1765-0.13%
2024/07/08086.80386.4086.00-3829-0.36%
2024/07/05587.1000.0086.8058560.58%
2024/07/04587.101.386.8486.903.78890.42%
2024/06/28590.0000.0089.3051,1030.45%
2024/06/21188.50288.6088.90-11,121-0.09%
2024/06/0700.00188.9090.10-11,167-0.09%
2024/05/3100.001088.5890.10-101,420-0.70%
2024/05/28288.90188.5088.7011,5550.06%
2024/05/27587.5000.0087.5051,7010.29%
2024/05/221088.0500.0088.50102,1000.48%
2024/05/21589.3000.0088.0052,1230.24%
2024/05/10185.1000.0086.5012,2850.04%
2024/04/29283.8000.0086.0022,3380.09%
2024/04/2400.00184.1084.80-12,321-0.04%
2024/04/1800.00187.1086.80-12,357-0.04%
2024/04/17488.6500.0087.8042,3560.17%
2024/04/15190.3000.0090.1012,3420.04%
2024/04/1200.00195.3094.00-12,339-0.04%
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-10天前
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕 相關文章
 
 
019小時13